These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35394113)

  • 1. Clinical outcomes of treatment with idebenone in Leber's hereditary optic neuropathy in the Netherlands: A national cohort study.
    van Everdingen JAM; Pott JWR; Bauer NJC; Krijnen AM; Lushchyk T; Wubbels RJ
    Acta Ophthalmol; 2022 Sep; 100(6):700-706. PubMed ID: 35394113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visual function in chronic Leber's hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset.
    Pemp B; Kircher K; Reitner A
    Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2751-2757. PubMed ID: 31482278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy.
    Catarino CB; von Livonius B; Priglinger C; Banik R; Matloob S; Tamhankar MA; Castillo L; Friedburg C; Halfpenny CA; Lincoln JA; Traber GL; Acaroglu G; Black GCM; Doncel C; Fraser CL; Jakubaszko J; Landau K; Langenegger SJ; Muñoz-Negrete FJ; Newman NJ; Poulton J; Scoppettuolo E; Subramanian P; Toosy AT; Vidal M; Vincent AL; Votruba M; Zarowski M; Zermansky A; Lob F; Rudolph G; Mikazans O; Silva M; Llòria X; Metz G; Klopstock T
    J Neuroophthalmol; 2020 Dec; 40(4):558-565. PubMed ID: 32991388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy.
    Klopstock T; Yu-Wai-Man P; Dimitriadis K; Rouleau J; Heck S; Bailie M; Atawan A; Chattopadhyay S; Schubert M; Garip A; Kernt M; Petraki D; Rummey C; Leinonen M; Metz G; Griffiths PG; Meier T; Chinnery PF
    Brain; 2011 Sep; 134(Pt 9):2677-86. PubMed ID: 21788663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of Japanese patients with Leber's hereditary optic neuropathy and idebenone trial: a prospective, interventional, non-comparative study.
    Ishikawa H; Masuda Y; Ishikawa H; Shikisima K; Goseki T; Kezuka T; Terao M; Miyazaki A; Matsumoto K; Nishikawa H; Gomi F; Mimura O
    Jpn J Ophthalmol; 2021 Jan; 65(1):133-142. PubMed ID: 33185792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idebenone for Leber's hereditary optic neuropathy.
    Gueven N
    Drugs Today (Barc); 2016 Mar; 52(3):173-81. PubMed ID: 27186591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altering neuronal circuitry with 4-aminopyridine for visual improvement in Leber's hereditary optic neuropathy (LHON).
    Chan JW; Sultan W; Karanjia R; Sadun AA
    Mitochondrion; 2022 Jan; 62():181-186. PubMed ID: 34915201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idebenone protects against retinal damage and loss of vision in a mouse model of Leber's hereditary optic neuropathy.
    Heitz FD; Erb M; Anklin C; Robay D; Pernet V; Gueven N
    PLoS One; 2012; 7(9):e45182. PubMed ID: 23028832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Effects of Idebenone on Leber Hereditary Optic Neuropathy.
    Zhao X; Zhang Y; Lu L; Yang H
    Curr Eye Res; 2020 Oct; 45(10):1315-1323. PubMed ID: 32111141
    [No Abstract]   [Full Text] [Related]  

  • 10. Idebenone: A Review in Leber's Hereditary Optic Neuropathy.
    Lyseng-Williamson KA
    Drugs; 2016 May; 76(7):805-13. PubMed ID: 27071925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leber's hereditary optic neuropathy: course of disease in consideration of idebenone treatment and type of mutation.
    Tonagel F; Wilhelm H; Richter P; Kelbsch C
    Graefes Arch Clin Exp Ophthalmol; 2021 Apr; 259(4):1009-1013. PubMed ID: 33337510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Raxone in the Leber optical neuropathy: Parisian experience].
    Orssaud C; Bidot S; Lamirel C; Brémond Gignac D; Touitou V; Vignal C
    J Fr Ophtalmol; 2019 Mar; 42(3):269-275. PubMed ID: 30712826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: The LEROS nonrandomized controlled trial.
    Yu-Wai-Man P; Carelli V; Newman NJ; Silva MJ; Linden A; Van Stavern G; Szaflik JP; Banik R; Lubiński W; Pemp B; Liao YJ; Subramanian PS; Misiuk-Hojło M; Newman S; Castillo L; Kocięcki J; Levin MH; Muñoz-Negrete FJ; Yagan A; Cherninkova S; Katz D; Meunier A; Votruba M; Korwin M; Dziedziak J; Jurkutė N; Harvey JP; La Morgia C; Priglinger C; Llòria X; Tomasso L; Klopstock T;
    Cell Rep Med; 2024 Mar; 5(3):101437. PubMed ID: 38428428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Past, present, and future in Leber's hereditary optic neuropathy].
    Oguchi Y
    Nippon Ganka Gakkai Zasshi; 2001 Dec; 105(12):809-27. PubMed ID: 11802455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants affecting NQO1 protein levels impact the efficacy of idebenone treatment in Leber hereditary optic neuropathy.
    Aleo SJ; Del Dotto V; Romagnoli M; Fiorini C; Capirossi G; Peron C; Maresca A; Caporali L; Capristo M; Tropeano CV; Zanna C; Ross-Cisneros FN; Sadun AA; Pignataro MG; Giordano C; Fasano C; Cavaliere A; Porcelli AM; Tioli G; Musiani F; Catania A; Lamperti C; Marzoli SB; De Negri A; Cascavilla ML; Battista M; Barboni P; Carbonelli M; Amore G; La Morgia C; Smirnov D; Vasilescu C; Farzeen A; Blickhaeuser B; Prokisch H; Priglinger C; Livonius B; Catarino CB; Klopstock T; Tiranti V; Carelli V; Ghelli AM
    Cell Rep Med; 2024 Feb; 5(2):101383. PubMed ID: 38272025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Response to idebenone and multivitamin therapy in Leber's hereditary optic neuropathy].
    Barnils N; Mesa E; Muñoz S; Ferrer-Artola A; Arruga J
    Arch Soc Esp Oftalmol; 2007 Jun; 82(6):377-80. PubMed ID: 17573650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leber's hereditary optic neuropathy - Case report.
    Iorga RE; Mihailovici R; Ozturk MR; Costin D
    Rom J Ophthalmol; 2018; 62(1):64-71. PubMed ID: 29796436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel use of idebenone in Leber's hereditary optic neuropathy in Hong Kong.
    Cheng SW; Ko CH; Yau SK; Mak C; Yuen YF; Lee CY
    Hong Kong Med J; 2014 Oct; 20(5):451-4. PubMed ID: 25307075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical Coherence Tomography of the Retinal Ganglion Cell Complex in Leber's Hereditary Optic Neuropathy and Dominant Optic Atrophy.
    Asanad S; Tian JJ; Frousiakis S; Jiang JP; Kogachi K; Felix CM; Fatemeh D; Irvine AG; Ter-Zakarian A; Falavarjani KG; Barboni P; Karanjia R; Sadun AA
    Curr Eye Res; 2019 Jun; 44(6):638-644. PubMed ID: 30649972
    [No Abstract]   [Full Text] [Related]  

  • 20. Visual prognosis better in eyes with less severe reduction of visual acuity one year after onset of Leber hereditary optic neuropathy caused by the 11,778 mutation.
    Mashima Y; Kigasawa K; Shinoda K; Wakakura M; Oguchi Y
    BMC Ophthalmol; 2017 Oct; 17(1):192. PubMed ID: 29047345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.